1. Home
  2. EQS vs ICU Comparison

EQS vs ICU Comparison

Compare EQS & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equus Total Return Inc.

EQS

Equus Total Return Inc.

N/A

Current Price

$0.54

Market Cap

12.3M

Sector

Finance

ML Signal

N/A

Logo SeaStar Medical Holding Corporation

ICU

SeaStar Medical Holding Corporation

N/A

Current Price

$0.82

Market Cap

10.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EQS
ICU
Founded
1991
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3M
10.6M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
EQS
ICU
Price
$0.54
$0.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
★ $10.00
AVG Volume (30 Days)
8.9K
★ 179.7K
Earning Date
01-01-0001
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,234,000.00
Revenue This Year
N/A
$62.07
Revenue Next Year
N/A
$50.00
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 814.07
52 Week Low
$0.53
$0.22
52 Week High
$2.05
$5.38

Technical Indicators

Market Signals
Indicator
EQS
ICU
Relative Strength Index (RSI) 33.83 19.50
Support Level N/A N/A
Resistance Level $1.05 $2.85
Average True Range (ATR) 0.05 0.20
MACD -0.01 -0.11
Stochastic Oscillator 3.92 0.04

Price Performance

Historical Comparison
EQS
ICU

About EQS Equus Total Return Inc.

Equus Total Return Inc is a United States-based closed-end management investment company. The company invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: